Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “STAT1 GOF”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07670156
What this trial is testing

Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

Who this might be right for
JAK1 GOFSTAT1 GOFSTAT3 GOF+2 more
Lisa Satter 30
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Not applicableAvailableNCT05561985
What this trial is testing

Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Who this might be right for
STAT1 Gain-of-Function Disease
Incyte Corporation

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation